XORTX THERAPEUTICS XRTXF news, videos and press releases
For more news please use our advanced search feature.
XORTX THERAPEUTICS XRTXF - More news...
XORTX THERAPEUTICS XRTXF - More news...
- XORTX to Present at Microcap Conference
- XORTX Announces Change of Auditor
- XORTX Adds Late Stage Gout Program to Pipeline
- XORTX Strengthens Executive Team
- XORTX Announces Presentation at the Rare and Genetic Disease Summit
- XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
- XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
- XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
- XORTX Initiates Precision Medicine Program
- XORTX Announces Results of Annual and Special Meeting of Shareholders
- XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
- XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
- Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
- XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
- XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
- XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024
- XORTX to Present at BIO International Convention 2024
- XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO
- XORTX Reprices Warrants Issued in Connection with Previous Private Placements
- XORTX Announces Publication of Key Research in ADPKD
- XORTX Welcomes New Member to the Board of Directors
- XORTX Announces Participation in Spring 2024 Investor Conferences
- XORTX Announces New Clinical Advisory Board Member
- XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
- XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
- XORTX Welcomes New Member to the Board of Directors
- XORTX Announces US ATM Offering
- XORTX Meets Nasdaq Continued Listing Requirements
- XORTX Clarifies Timing for Share Consolidation
- XORTX Announces Share Consolidation
